Dantrolene has previously been shown to reduce Ca2+ spark frequency and arrhythmogenicity in induced pluripotent stem cells derived from a CPVT patient carrying a RYR2 S406L mutation (Jung et al. 2012). This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.